ArticleEuropean journal of epidemiology2024
Cause-specific excess mortality in Denmark, Finland, Norway, and Sweden during the COVID-19 pandemic 2020-2022: a study using nationwide population data.
Article in European journal of epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Forecast of dementia prevalence in Germany and subnational regions until 2060 using microsimulation.European journal of epidemiology · 2026Article
- Inequality in life expectancy losses by education in Finland during COVID-19 pandemic.International journal for equity in health · 2026Article
- Antibiotic prescriptions to preschool children with respiratory tract infections in primary healthcare.JAC-antimicrobial resistance · 2026Article
- Excess life-years and productive life-years lost in Poland through the COVID-19 pandemic and post-pandemic years.Archives of public health = Archives belges de sante publique · 2026Article
- Changes in life expectancy and life span equality during the COVID-19 epidemic in 2020-22 in Japan.PloS one · 2026Article
- COVID-19 disrupted patterns of cause-specific mortality in Switzerland.International journal of public health · 2026Article
- Excess mortality and healthcare costs during the COVID-19 pandemic among patients with ten major chronic diseases in South korea: a nationwide analysis.BMC infectious diseases · 2025Observational
- Decomposing life expectancy changes in Spain in the COVID-19 pandemic and post-pandemic periods.BMC public health · 2025Article
- Exploring health system resilience during the COVID-19 pandemic in Sweden: an interrupted time series analysis of service utilisation and sociodemographic differences.BMC health services research · 2025Article
- Excess respiratory, circulatory, neoplasm, and other mortality rates during the Covid-19 pandemic in the EU and their implications.Epidemiology and infection · 2025Article
- Excess and reduced work absence during COVID-19 in Poland: insights from cause-specific time-series models.Population health metrics · 2025Article
- Beyond death counts: how COVID-19 affected excess mortality and productive life-years lost across 28 European states, 2020-2023.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
While there is substantial evidence on excess mortality in the first two years of the COVID-19 pandemic, no study has conducted a cause-specific analysis of excess mortality for the whole period 2020-2022 across multiple countries. We examined cause-specific excess mortality during 2020-2022 in Denmark, Finland, Norway, and Sweden-four countries with similar demographics and welfare provisions, which implemented different pandemic response policies. To this end, we utilized nationwide register-based information on annual cause-specific deaths stratified by age and sex, and applied linear regression models to predict mortality in 2020-2022 based on the reference period 2010-2019. Excess deaths were obtained by contrasting actual and expected deaths. Additional analyses employed standardization to a common population, as well as population adjustments to account for previous deaths. Our results showed that, besides deaths due to COVID-19 (a total of 32,491 during 2020-2022), all countries experienced excess deaths due to cardiovascular diseases (in total 11,610 excess deaths), and under-mortality due to respiratory diseases other than COVID-19 (in total 9878) and dementia (in total 8721). The excess mortality due to cardiovascular diseases was particularly pronounced in Finland and Norway in 2022, and the under-mortality due to dementia was particularly pronounced in Sweden in 2021-2022. In conclusion, while COVID-19 deaths emerge as the most apparent consequence of the pandemic, our findings suggest that mortality has also been influenced by substitutions between different causes of death and over time, as well as indirect consequences of COVID-19 infection and pandemic responses-albeit to different extents in the different countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.